Morgan Stanley Maintains Overweight on enGene Holdings, Raises Price Target to $19
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Jeffrey Hung maintains enGene Holdings (NASDAQ:ENGN) with a Overweight and raises the price target from $18 to $19.
Morgan Stanley analyst Jeffrey Hung maintains enGene Holdings (NASDAQ:ENGN) with a Overweight and raises the price target from $18 to $19.